PrEP: controversy, agency and ownership
Pre‐exposure prophylaxis (PrEP) has been and continues to be an intervention that causes controversy and debate between stakeholders involved in providing or advocating for it, and within communities in need of it. These controversies extend beyond the intrinsically complex issues of making it avail...
Gespeichert in:
Veröffentlicht in: | Journal of the International AIDS Society 2016-10, Vol.19 (7(Suppl 6)), p.21120-n/a |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 7(Suppl 6) |
container_start_page | 21120 |
container_title | Journal of the International AIDS Society |
container_volume | 19 |
creator | Cairns, Gus P Race, Kane Goicochea, Pedro |
description | Pre‐exposure prophylaxis (PrEP) has been and continues to be an intervention that causes controversy and debate between stakeholders involved in providing or advocating for it, and within communities in need of it. These controversies extend beyond the intrinsically complex issues of making it available. In this commentary, some of the possible roots of the air of dissent and drama that accompanies PrEP are explored. The similarities between the controversies that dogged the earliest human trials of PrEP and the ones we see today in the era of licensing and implementation are explored. We outline five mediating principles or cultural norms that may influence arguments about PrEP differently. Three areas of specific concern are identified: medical risk versus benefit, distrust and fear of healthcare interventions, and fears for individual responsibility and community cohesion. The fear that PrEP may somehow represent a loss of control over one or more of these domains is suggested as an underlying factor. The development of countervailing measures, to institute greater community “ownership” of PrEP, and concomitant improvements in the sense of individual agency over sexual risk are outlined and recommended. |
doi_str_mv | 10.7448/IAS.19.7.21120 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476679572</galeid><sourcerecordid>A476679572</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6270-8b6bd80ffe5c0963367d2a8662a7f54764d63d73337a7e9828d2157fe53f58063</originalsourceid><addsrcrecordid>eNqFkt9rUzEUxy-iuLn56qMUBPXBe83vk_gglDFnZbCB-hzS3Nw24zbpkt6N_vdmazc6KUoeEk4-53vOSb5V9QajBhiTnyfjnw1WDTQEY4KeVYcYuKyJ4OT5zvmgepXzFUKCSKZeVgcEQCAh1WH14TKdXn4Z2RhWKd64lNefRmbmgl2PTGhH8TaU2Nwvj6sXnemze73dj6rf305_nXyvzy_OJifj89oKAqiWUzFtJeo6xy1SglIBLTFSCGKg4wwEawVtgVIKBpySRLYEcyg47bhEgh5VXze6y2G6cK11pS_T62XyC5PWOhqvn94EP9ezeKM5AgxMFYGPW4EUrweXV3rhs3V9b4KLQ9ZYUs4RYwgK-u4v9CoOKZTxNEUCBGZKiH9RhCiEFFX3ZbfUzPRO-9DF0p29K63HZWwBigMpVL2HKs_tyigxuM6X8BO-2cOX1bqFt3sT3u8kzJ3pV_Mc-2HlY8h7lW2KOSfXPT4xRvrOWbo4S2OlQd87qyS83f2YR_zBSgVgG-C29LT-j5z-MRlvdP8AE47S0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290093949</pqid></control><display><type>article</type><title>PrEP: controversy, agency and ownership</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Cairns, Gus P ; Race, Kane ; Goicochea, Pedro</creator><creatorcontrib>Cairns, Gus P ; Race, Kane ; Goicochea, Pedro</creatorcontrib><description>Pre‐exposure prophylaxis (PrEP) has been and continues to be an intervention that causes controversy and debate between stakeholders involved in providing or advocating for it, and within communities in need of it. These controversies extend beyond the intrinsically complex issues of making it available. In this commentary, some of the possible roots of the air of dissent and drama that accompanies PrEP are explored. The similarities between the controversies that dogged the earliest human trials of PrEP and the ones we see today in the era of licensing and implementation are explored. We outline five mediating principles or cultural norms that may influence arguments about PrEP differently. Three areas of specific concern are identified: medical risk versus benefit, distrust and fear of healthcare interventions, and fears for individual responsibility and community cohesion. The fear that PrEP may somehow represent a loss of control over one or more of these domains is suggested as an underlying factor. The development of countervailing measures, to institute greater community “ownership” of PrEP, and concomitant improvements in the sense of individual agency over sexual risk are outlined and recommended.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.7448/IAS.19.7.21120</identifier><identifier>PMID: 27760689</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; AIDS/HIV ; Anti-HIV Agents - therapeutic use ; Attitude to Health ; Clinical trials ; Collaboration ; Communitarianism ; Condoms ; Culture ; Disease prevention ; Health aspects ; Health services ; HIV ; HIV Infections - drug therapy ; HIV Infections - prevention & control ; HIV prevention ; HIV prevention implementation ; Human immunodeficiency virus ; Humans ; Internet ; key affected populations ; men who have sex with men ; Pre-Exposure Prophylaxis ; Prevention ; Prophylaxis ; Public health ; Researchers ; Safety and security measures ; Sexual behavior ; Sexually transmitted diseases ; Social networks ; sociology of HIV ; Viewpoint</subject><ispartof>Journal of the International AIDS Society, 2016-10, Vol.19 (7(Suppl 6)), p.21120-n/a</ispartof><rights>2016 Cairns G P et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2016 International AIDS Society</rights><rights>2016. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Cairns GP et al; licensee International AIDS Society 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6270-8b6bd80ffe5c0963367d2a8662a7f54764d63d73337a7e9828d2157fe53f58063</citedby><cites>FETCH-LOGICAL-c6270-8b6bd80ffe5c0963367d2a8662a7f54764d63d73337a7e9828d2157fe53f58063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,1414,11545,27907,27908,45557,45558,46035,46459,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27760689$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cairns, Gus P</creatorcontrib><creatorcontrib>Race, Kane</creatorcontrib><creatorcontrib>Goicochea, Pedro</creatorcontrib><title>PrEP: controversy, agency and ownership</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Pre‐exposure prophylaxis (PrEP) has been and continues to be an intervention that causes controversy and debate between stakeholders involved in providing or advocating for it, and within communities in need of it. These controversies extend beyond the intrinsically complex issues of making it available. In this commentary, some of the possible roots of the air of dissent and drama that accompanies PrEP are explored. The similarities between the controversies that dogged the earliest human trials of PrEP and the ones we see today in the era of licensing and implementation are explored. We outline five mediating principles or cultural norms that may influence arguments about PrEP differently. Three areas of specific concern are identified: medical risk versus benefit, distrust and fear of healthcare interventions, and fears for individual responsibility and community cohesion. The fear that PrEP may somehow represent a loss of control over one or more of these domains is suggested as an underlying factor. The development of countervailing measures, to institute greater community “ownership” of PrEP, and concomitant improvements in the sense of individual agency over sexual risk are outlined and recommended.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Attitude to Health</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Communitarianism</subject><subject>Condoms</subject><subject>Culture</subject><subject>Disease prevention</subject><subject>Health aspects</subject><subject>Health services</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - prevention & control</subject><subject>HIV prevention</subject><subject>HIV prevention implementation</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Internet</subject><subject>key affected populations</subject><subject>men who have sex with men</subject><subject>Pre-Exposure Prophylaxis</subject><subject>Prevention</subject><subject>Prophylaxis</subject><subject>Public health</subject><subject>Researchers</subject><subject>Safety and security measures</subject><subject>Sexual behavior</subject><subject>Sexually transmitted diseases</subject><subject>Social networks</subject><subject>sociology of HIV</subject><subject>Viewpoint</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqFkt9rUzEUxy-iuLn56qMUBPXBe83vk_gglDFnZbCB-hzS3Nw24zbpkt6N_vdmazc6KUoeEk4-53vOSb5V9QajBhiTnyfjnw1WDTQEY4KeVYcYuKyJ4OT5zvmgepXzFUKCSKZeVgcEQCAh1WH14TKdXn4Z2RhWKd64lNefRmbmgl2PTGhH8TaU2Nwvj6sXnemze73dj6rf305_nXyvzy_OJifj89oKAqiWUzFtJeo6xy1SglIBLTFSCGKg4wwEawVtgVIKBpySRLYEcyg47bhEgh5VXze6y2G6cK11pS_T62XyC5PWOhqvn94EP9ezeKM5AgxMFYGPW4EUrweXV3rhs3V9b4KLQ9ZYUs4RYwgK-u4v9CoOKZTxNEUCBGZKiH9RhCiEFFX3ZbfUzPRO-9DF0p29K63HZWwBigMpVL2HKs_tyigxuM6X8BO-2cOX1bqFt3sT3u8kzJ3pV_Mc-2HlY8h7lW2KOSfXPT4xRvrOWbo4S2OlQd87qyS83f2YR_zBSgVgG-C29LT-j5z-MRlvdP8AE47S0A</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Cairns, Gus P</creator><creator>Race, Kane</creator><creator>Goicochea, Pedro</creator><general>International AIDS Society</general><general>John Wiley & Sons, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201610</creationdate><title>PrEP: controversy, agency and ownership</title><author>Cairns, Gus P ; Race, Kane ; Goicochea, Pedro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6270-8b6bd80ffe5c0963367d2a8662a7f54764d63d73337a7e9828d2157fe53f58063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Attitude to Health</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Communitarianism</topic><topic>Condoms</topic><topic>Culture</topic><topic>Disease prevention</topic><topic>Health aspects</topic><topic>Health services</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - prevention & control</topic><topic>HIV prevention</topic><topic>HIV prevention implementation</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Internet</topic><topic>key affected populations</topic><topic>men who have sex with men</topic><topic>Pre-Exposure Prophylaxis</topic><topic>Prevention</topic><topic>Prophylaxis</topic><topic>Public health</topic><topic>Researchers</topic><topic>Safety and security measures</topic><topic>Sexual behavior</topic><topic>Sexually transmitted diseases</topic><topic>Social networks</topic><topic>sociology of HIV</topic><topic>Viewpoint</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cairns, Gus P</creatorcontrib><creatorcontrib>Race, Kane</creatorcontrib><creatorcontrib>Goicochea, Pedro</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cairns, Gus P</au><au>Race, Kane</au><au>Goicochea, Pedro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PrEP: controversy, agency and ownership</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2016-10</date><risdate>2016</risdate><volume>19</volume><issue>7(Suppl 6)</issue><spage>21120</spage><epage>n/a</epage><pages>21120-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Pre‐exposure prophylaxis (PrEP) has been and continues to be an intervention that causes controversy and debate between stakeholders involved in providing or advocating for it, and within communities in need of it. These controversies extend beyond the intrinsically complex issues of making it available. In this commentary, some of the possible roots of the air of dissent and drama that accompanies PrEP are explored. The similarities between the controversies that dogged the earliest human trials of PrEP and the ones we see today in the era of licensing and implementation are explored. We outline five mediating principles or cultural norms that may influence arguments about PrEP differently. Three areas of specific concern are identified: medical risk versus benefit, distrust and fear of healthcare interventions, and fears for individual responsibility and community cohesion. The fear that PrEP may somehow represent a loss of control over one or more of these domains is suggested as an underlying factor. The development of countervailing measures, to institute greater community “ownership” of PrEP, and concomitant improvements in the sense of individual agency over sexual risk are outlined and recommended.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>27760689</pmid><doi>10.7448/IAS.19.7.21120</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2016-10, Vol.19 (7(Suppl 6)), p.21120-n/a |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071749 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Acquired immune deficiency syndrome AIDS AIDS/HIV Anti-HIV Agents - therapeutic use Attitude to Health Clinical trials Collaboration Communitarianism Condoms Culture Disease prevention Health aspects Health services HIV HIV Infections - drug therapy HIV Infections - prevention & control HIV prevention HIV prevention implementation Human immunodeficiency virus Humans Internet key affected populations men who have sex with men Pre-Exposure Prophylaxis Prevention Prophylaxis Public health Researchers Safety and security measures Sexual behavior Sexually transmitted diseases Social networks sociology of HIV Viewpoint |
title | PrEP: controversy, agency and ownership |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PrEP:%20controversy,%20agency%20and%20ownership&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Cairns,%20Gus%20P&rft.date=2016-10&rft.volume=19&rft.issue=7(Suppl%206)&rft.spage=21120&rft.epage=n/a&rft.pages=21120-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.7448/IAS.19.7.21120&rft_dat=%3Cgale_pubme%3EA476679572%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290093949&rft_id=info:pmid/27760689&rft_galeid=A476679572&rfr_iscdi=true |